Why the study?
Does the dose of captopril correlate with arterial blood pressure and plasma renin, aldosterone, and potassium levels in severely hypertensive patients?
Does the dose of captopril correlate with arterial blood pressure and plasma renin, aldosterone, and potassium levels in severely hypertensive patients?
Captopril demonstrates a dose-dependent effect on blood pressure and renin-angiotensin-aldosterone system parameters in severely hypertensive patients.
Answers are grounded in this paper and cite their sources.
Supports captopril dose titration in severe hypertension; confirms dose-dependent effects on BP and RAAS biomarkers in an RCT.
In a double-blind randomized study, the dose response to captopril was studied in 12 severely hypertensive patients whose blood pressure had been previously controlled by this converting enzyme inhibitor, either in association with a diuretic (seven patients), or with a diuretic and a beta-blocker (five patients). All patients received in random sequence 32.5, 75, and 150 mg/day of captopril in three divided doses. Significant correlations were revealed between the dose administered and the levels of arterial blood pressure, plasma renin, plasma aldosterone and plasma potassium. Under the conditions of this study, dose-response curves were obtained for concentrations of captopril between 0.5 and 4 mg/day/kg body weight.
No takes yet. Share an insight, caveat, or question.
Aldigier et al. (1981) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: